Creation of human tumour cells with defined genetic elements
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
During malignant transformation, cancer cells acquire genetic mutations that override the normal mechanisms controlling cellular proliferation. Primary rodent cells are efficiently converted into tumorigenic cells by the coexpression of cooperating oncogenes. However, similar experiments with human cells have consistently failed to yield tumorigenic transformants, indicating a fundamental difference in the biology of human and rodent cells. The few reported successes in the creation of human tumour cells have depended on the use of chemical or physical agents to achieve immortalization, the selection of rare, spontaneously arising immortalized cells, or the use of an entire viral genome. We show here that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast cells. These results demonstrate that disruption of the intracellular pathways regulated by large-T, oncogenic ras and telomerase suffices to create a human tumor cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“expression of telomerase in conjunction with expression of simian virus 40 large T oncoprotein and an oncogenic allele of H-ras has been shown to promote tumorigenic conversion of normal human cells (28).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [28]
In the citing paper
“Interestingly, high telomerase expression, which is associated with long telomeres, is commonly found in adult stem/progenitor cell compartments, including the stem cells in hair follicles, whereas low telomerase expression has been detected in human fibroblasts and epithelial cells [115, 116].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [116]
In the citing paper
“In studies employing a p53 allele (R172P) capable of enforcing senescence but defective in apoptosis, dysfunctional telomeres strongly inhibited the spontaneous lymphomas and sarcomas to which p53-mutant mice normally succumb.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“However, the R172P allele was not as efficient as wild-type p53 in inhibiting chemically induced papillomas”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
In the citing paper
“suggesting that senescence was insufficient to block transformation of keratinocytes in this model (94).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [94]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Self-citationA survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206
Absence of cancer–associated changes in human fibroblasts immortalized with telomerase
Morales, C. P., Holt, S. E., Ouellette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., & Shay, J. W. (1999) · Nature Genetics · doi:10.1038/5063 · Cited by 803
Kim, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.13.2595 · Cited by 686
Jiang, X.-R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tlsty, T. D., et al. (1999) · Nature Genetics · doi:10.1038/5056 · Cited by 668
Research works printed but not linked: 1
- Kang, J.-S.et al. Involvement of tyrosine phosphorylation of p185c-erb/neu in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells. Mol. Carcinogen.21, 225–233 (1998). · DOI
Cited by
Items 401–500 of 1,011
Immortalisation and transformation revisited
Drayton, S., & Peters, G. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00271-4 · Cited by 148
Mice without telomerase: what can they teach us about human cancer?
Artandi, S. E., & DePinho, R. A. (2000) · Nature Medicine · doi:10.1038/78595 · Cited by 126
Rotem, A., Janzer, A., Izar, B., Ji, Z., Doench, J. G., Garraway, L. A., & Struhl, K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505979112 · Cited by 126
Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA
Lim, K.-H., Brady, D. C., Kashatus, D. F., Ancrile, B. B., Der, C. J., Cox, A. D., & Counter, C. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00916-08 · Cited by 126
Self-citationDerivation of human tumor cells in vitro without widespread genomic instability.
Zimonjic, D. B., Brooks, M. W., Popescu, N. C., Weinberg, R. A., & Hahn, W. C. (2001) · PubMed · Cited by 130
Self-citationHanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., 谷山真由美, Nakamura, S., Uemura, M., Takuma, Y., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00736-4 · Cited by 126
NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells
Gupta, R., Hong, D., Iborra, F., Sarno, S., & Enver, T. (2007) · Science · doi:10.1126/science.1136031 · Cited by 126
In vitro generation of human cells with cancer stem cell properties
Scaffidi, P., & Misteli, T. (2011) · Nature Cell Biology · doi:10.1038/ncb2308 · Cited by 132
Baverstock, K. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00100-7 · Cited by 135
Human Papillomavirus Type 16 E6 Induces Self-Ubiquitination of the E6AP Ubiquitin-Protein Ligase
Kao, W. H., Beaudenon, S. L., Talis, A. L., Huibregtse, J. M., & Howley, P. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6408-6417.2000 · Cited by 125
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 124
Evolving views of telomerase and cancer
Blasco, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00085-0 · Cited by 123
Are tumours angiogenesis‐dependent?
Verheul, H. M. W., Voest, E. E., & Schlingemann, R. O. (2003) · The Journal of Pathology · doi:10.1002/path.1473 · Cited by 143
Heald, R. A., Modi, C., Cookson, J. C., Hutchinson, I. S., Laughton, C. A., Gowan, S. M., Kèlland, L. R., & Stevens, M. F. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm011015q · Cited by 129
Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication
O’Shea, C. C., Klupsch, K., Choi, S., Bagus, B., Soria, C. T., Shen, J., McCormick, F. P., & Stokoe, D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600597 · Cited by 131
Calabrese, P. P., Tavaré, S., & Shibata, D. K. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63220-8 · Cited by 121
Hou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Björkholm, M., Arsenian‐Henriksson, M., Gruber, A., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5462 · Cited by 134
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
Border Forces and Friction Control Epithelial Closure Dynamics
Cochet-Escartin, O., Ranft, J., Silberzan, P., & Marcq, P. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.015 · Cited by 122
Is carcinogenesis a form of speciation?
DUESBERG, P. H., Mandrioli, D., McCormack, A. A., & Nicholson, J. M. (2011) · Cell Cycle · doi:10.4161/cc.10.13.16352 · Cited by 135
Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus.
Ricciardiello, L., Baglioni, M., Giovannini, C., Pariali, M., Cenacchi, G., Ripalti, A., Landini, M. P., Sawa, H., Nagashima, K., Frisque, R. J., et al. (2003) · PubMed · Cited by 121
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
Hong, X., Nguyen, H. T., Chen, Q., Zhang, R., Hagman, Z., Voorhoeve, P. M., & Cohen, S. M. (2014) · The EMBO Journal · doi:10.15252/embj.201489385 · Cited by 121
“As shown previously (Hahn et al , 2002; Voorhoeve et al , 2006), these cells were capable of anchorage independent growth when expressing Ras V12 (Fig 1B; similar result were obtained with K-Ras G12V and N-Ras G12V , Supplementary Fig S1). shRNA-mediated depletion of SOCS5/6 was sufficient to…”
Li, Y., Liu, L., & Tollefsbol, T. O. (2010) · The FASEB Journal · doi:10.1096/fj.09-149328 · Cited by 120
The STAT3 oncogene as a predictive marker of drug resistance
Barré, B., Vigneron, A. M., Perkins, N. D., Roninson, I. B., Gamelin, E. C., & Coqueret, O. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.001 · Cited by 129
McFall, A., ülkuü, A., Lambert, Q. T., Kusa, A., Rogers-Graham, K., & Der, C. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5488-5499.2001 · Cited by 120
“For example, while primary mouse fibroblasts undergo senescence in response to activated Ras expression, the additional loss of p53 or Rb-1 tumor suppressor function allows Ras to cause growth transformation ( 22 , 50).”
BackgroundÖğretmen, B., Schady, D. A., Usta, J. A., Wood, R., Kraveka, J. M., Luberto, C., Birbes, H., Hannun, Y. A., & Obeid, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100314200 · Cited by 128
Nishi, M., Sakai, Y., Akutsu, H., Nagashima, Y., Quinn, G., Masui, S., Kimura, H., Perrem, K., Umezawa, A., Yamamoto, N., et al. (2013) · Oncogene · doi:10.1038/onc.2012.614 · Cited by 124
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Wang, Y., Lee, Y.-M., Baitsch, L., Huang, A., Xiang, Y., Tong, H., Lako, A., Von, T., Choi, C., Lim, E., et al. (2014) · eLife · doi:10.7554/elife.01763 · Cited by 119
Hamczyk, M. R., Villa‐Bellosta, R., Quesada, V., Gonzalo, P., Vidak, S., Nevado, R. M., Andrés‐Manzano, M. J., Misteli, T., López‐Otín, C., & Andrés, V. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809736 · Cited by 119
Rotblat, B., Ehrlich, M., Haklai, R., & Kloog, Y. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)00432-6 · Cited by 119
MDR1 expression identifies human melanoma stem cells
Keshet, G. I., Goldstein, I., Itzhaki, O., Cesarkas, K., Shenhav, L., Yakirevitch, A., Treves, A. J., Schachter, J., Amariglio, N., & Rechavi, G. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.022 · Cited by 124
Aneuploidy Precedes and Segregates with Chemical Carcinogenesis
DUESBERG, P. H., Li, R., Rasnick, D., Rausch, C., Willer, A., Kraemer, A., Yerganian, G., & Hehlmann, R. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00236-8 · Cited by 116
Targeted Disruption of Mouse Fibroblast Activation Protein
Niedermeyer, J., Kriz, M., Hilberg, F., Garin-Chesa, P., Bamberger, U., Lenter, M. C., Park, J., Viertel, B., Püschner, H., Mauz, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1089-1094.2000 · Cited by 119
Immortal Activated Human Hepatic Stellate Cells Generated by Ectopic Telomerase Expression
Schnabl, B., Choi, Y. H., Olsen, J. C., Hagedorn, C. H., & Brenner, D. A. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780426 · Cited by 131
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.543-554.2003 · Cited by 119
Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility
Xia, M., & Land, H. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1208 · Cited by 127
Wu, Z., Qu, J., & Liu, G.-H. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00775-3 · Cited by 118
SV40 infection induces telomerase activity in human mesothelial cells
Foddis, R., Rienzo, A. D., Broccoli, D., Bocchetta, M., Stekala, E., Rizzo, P., Tosolini, A., Grobelny, J. V., Jhanwar, S. C., Pass, H. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205203 · Cited by 123
ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens
Shao, D. D., Tsherniak, A., Gopal, S., Weir, B. A., Tamayo, P., Stransky, N., Schumacher, S. E., Zack, T. I., Beroukhim, R., Garraway, L. A., et al. (2013) · Genome Research · doi:10.1101/gr.143586.112 · Cited by 118
Self-citationCancer-associated fibroblasts support vascular growth through mechanical force
Sewell-Loftin, M. K., Bayer, S. V. H., Crist, E., Hughes, T., Joison, S. M., Longmore, G. D., & George, S. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-13006-x · Cited by 138
Sans, C. L., Satterwhite, D. J., Stoltzman, C. A., Breen, K. T., & Ayer, D. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-05 · Cited by 117
Telomere biology in human aging and aging syndromes
Klapper, W., Parwaresch, R., & Krupp, G. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00223-8 · Cited by 134
On the road to immortality: hTERT upregulation in cancer cells
Janknecht, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00356-4 · Cited by 116
Qian, J., Niu, J., Li, M., Chiao, P. J., & Tsao, M.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3208 · Cited by 115
Technological Overview of iPS Induction from Human Adult Somatic Cells
Bayart, E., & Cohen-Haguenauer, O. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020002 · Cited by 113
Targeting homologous recombination repair defects in cancer
Evers, B., Helleday, T., & Jonkers, J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.06.001 · Cited by 127
Origin of carcinoma associated fibroblasts
Haviv, I., Polyak, K., Qiu, W., Hu, M., & Campbell, I. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7669 · Cited by 114
EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
Krusche, B., Ottone, C., Clements, M. P., Johnstone, E. R., Goetsch, K., Lieven, H., Mota, S. G., Singh, P., Khadayate, S., Ashraf, A., et al. (2016) · eLife · doi:10.7554/elife.14845 · Cited by 112
Sullivan, C. S., Cantalupo, P. G., & Pipas, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6233-6243.2000 · Cited by 131
Liu, N., Ding, D., Hao, W., Yang, F., Wu, X., Wang, M., Xu, X., Ju, Z., Liu, J., Song, Z., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw549 · Cited by 115
Evolution of telomere maintenance and tumour suppressor mechanisms across mammals
Tian, X., Doerig, K., Park, R., Can Ran Qin, A., Hwang, C., Neary, A., Gilbert, M., Seluanov, A., & Gorbunova, V. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0443 · Cited by 111
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
Macaluso, M., Paggi, M. G., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206955 · Cited by 126
Noonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway
Tidyman, W. E., & Rauen, K. A. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000902 · Cited by 110
Qi, Y., He, Q., Ma, Y.-F., Du, Y.-W., Liu, G., Li, Y., Tsao, G. S., Ngai, S. M., & Chiu, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21727 · Cited by 117
Parkhurst, M. R., Riley, J. P., Igarashi, T., Li, Y., Robbins, P. F., & Rosenberg, S. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0325 · Cited by 120
Zhang, M., Wang, Z., Obazee, O., Jia, J., Childs, E. J., Hoskins, J., Figlioli, G., Mocci, E., Collins, I., Chung, C. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11041 · Cited by 110
Genetic dissection of histone deacetylase requirement in tumor cells
Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L., & Olson, E. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903139106 · Cited by 109
Vickers, M. A., Jackson, G. H., & Taylor, P. R. A. (2000) · Leukemia · doi:10.1038/sj.leu.2401722 · Cited by 110
Recent advances in research on multistage tumorigenesis
Compagni, A., & Christofori, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1309 · Cited by 110
Restricted 12p Amplification and RAS Mutation in Human Germ Cell Tumors of the Adult Testis
Roelofs, H., Mostert, M. C., Pompe, K., Zafarana, G., van Oorschot, M., van Gurp, R. J. H. L. M., Gillis, A., Stoop, H., Beverloo, B. H. B., Oosterhuis, J. W., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64631-7 · Cited by 110
Haplo-insufficiency? Let me count the ways: Figure 1.Preprint
Quon, K. C., & Berns, A. J. M. (2001) · Genes & Development · doi:10.1101/gad.949001 · Cited by 109
Li, Y., Chen, H., Hardy, T. M., & Tollefsbol, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054369 · Cited by 117
Venetsanakos, E., Mirza, A. M., Fanton, C. P., Romanov, S. R., Tlsty, T. D., & McMahon, M. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5424 · Cited by 122
Methylation reveals a niche: stem cell succession in human colon crypts
Kim, K., & Shibata, D. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205604 · Cited by 114
Human polyomaviruses and brain tumors
White, M. K., Gordon, J., Reiss, K., Valle, L. D., Croul, S. E., Giordano, A., Darbinyan, A., & Khalili, K. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.04.007 · Cited by 108
Lansdorp, P. M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.172 · Cited by 108
Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.038 · Cited by 108
Self-citationChiang, Y. J., Hemann, M. T., Hathcock, K. S., Tessarollo, L., Feigenbaum, L., Hahn, W. C., & Hodes, R. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7024-7031.2004 · Cited by 108
Self-citationA Network of Genetic Events Sufficient to Convert Normal Human Cells to a Tumorigenic State
Kendall, S. D., Linardic, C. M., Adam, S. J., & Counter, C. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1543 · Cited by 108
Self-citationC-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity
Banik, S. S. R., Guo, C., Smith, A. C., Margolis, S. S., Richardson, D. A., Tirado, C. A., & Counter, C. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.17.6234-6246.2002 · Cited by 109
Self-citationQuin, J. E., Chan, K. T., Devlin, J. R., Cameron, D. P., Diesch, J., Cullinane, C. M., Ahern, J., Khot, A. S., Hein, N., George, A. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10452 · Cited by 122
Imetelstat (GRN163L) - Telomerase-Based Cancer Therapy
Röth, A., Harley, C. B., & Baerlocher, G. M. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_16 · Cited by 126
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
Okamoto, N., Yasukawa, M., Nguyen, C. L., Kasim, V., Maida, Y., Possemato, R., Shibata, T., Ligon, K. L., Fukami, K., Hahn, W. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015171108 · Cited by 108
Self-citationCurrent Concepts on the Molecular Biology of Osteosarcoma
Gorlick, R. G. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_27 · Cited by 116
Shao, R., & Guo, X. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.033 · Cited by 114
Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress
Rubio, M. Á., Davalos, A. R., & Campisi, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.004 · Cited by 115
Blueprint for antimicrobial hit discovery targeting metabolic networks
Shen, Y., Liu, J., Estiu, G., Isin, B., Ahn, Y.-Y., Lee, D.-S., Barabási, A.-L., Kapatral, V., Wiest, O., & Oltvai, Z. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909181107 · Cited by 106
Drug Resistance in Cancer: A Perspective
Goldie, J. H. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013164609041 · Cited by 124
The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program
Elliott, K., Ge, K., Du, W., & Prendergast, G. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203681 · Cited by 106
“…was not invalidated by the ®nding that p53 and Rb were dispensable for Bin1-induced death, because T antigen has additional role(s) in immortalization and human cell transformation beyond inactivation of these tumor suppressors (Conzen and Cole, 1995; Hahn et al., 1999; Powell et al., 1999).”
Helicobacter pylori and the risk of benign and malignant biliary tract disease
Bulajic, M. M., Maisonneuve, P., Schneider‐Brachert, W., Müller, P., Reischl, U., Stimec, B. V., Lehn, N., Lowenfels, A. B., & Löhr, M. J. (2002) · Cancer · doi:10.1002/cncr.10893 · Cited by 106
Biology of telomeres: lessons from budding yeast
Kupiec, M. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12054 · Cited by 122
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
Bangham, C. R. M., Cook, L. B., & Melamed, A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.003 · Cited by 105
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
Bellon, M., & Nicot, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm269 · Cited by 104
Vonderheide, R. H., Anderson, K. S., Hahn, W. C., Butler, M. O., Schultze, J. L., & Nadler, L. M. (2001) · PubMed · Cited by 118
Self-citationBeyond the Oncogene Paradigm: Understanding Complexity in Cancerogenesis
Bizzarri, M., Cucina, A., Conti, F., & D’Anselmi, F. (2008) · Acta Biotheoretica · doi:10.1007/s10441-008-9047-8 · Cited by 115
Nakajima, A., Tauchi, T., Sashida, G., Sumi, M., Abe, K., Yamamoto, K., Ohyashiki, J. H., & Ohyashiki, K. (2003) · Leukemia · doi:10.1038/sj.leu.2402825 · Cited by 113
Stem Cell Chromatin Patterns: An Instructive Mechanism for DNA Hypermethylation?
Ohm, J. E., & Baylin, S. B. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4210 · Cited by 102
Aznar, S., Valerón, P. F., del Rincon, S. V., Pérez, L. F., Perona, R., & Lacal, J. C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.10.3282 · Cited by 103
A second chance for telomerase reverse transcriptase in anticancer immunotherapy
Zanetti, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.67 · Cited by 109
Smith, K. D., Mezhir, J. J., Bickenbach, K. A., Veerapong, J., Charron, J., Posner, M. C., Roizman, B., & Weichselbaum, R. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1110-1120.2006 · Cited by 102
Lin, S. S., Bassik, M. C., Suh, H., Nishino, M., Arroyo, J. D., Hahn, W. C., Korsmeyer, S. J., & Roberts, T. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602648200 · Cited by 102
Self-citationWu, K., Katiyar, S., Li, A., Liu, M., Ju, X., Popov, V. M., Jiao, X., Lisanti, M. P., Casola, A., & Pestell, R. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802085105 · Cited by 108
The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay
Cimino-Reale, G. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.e35 · Cited by 101
Aneuploidy and Cancer: From Correlation to Causation
DUESBERG, P. H., Li, R., Fabarius, A. C., & Hehlmann, R. (2006) · KARGER eBooks · doi:10.1159/000092963 · Cited by 118
Chen, H., Zhang, W., Sun, X., Yoshimoto, M., Chen, Z., Zhu, W., Liu, J., Shen, Y., Yong, W., Li, D., et al. (2013) · Development · doi:10.1242/dev.089920 · Cited by 109
Histone deacetylase inhibitors selectively suppress expression of HDAC7
Dokmanovic, M., Perez, G., Xu, W., Ngo, L., Clarke, C., Parmigiani, R. B., & Marks, P. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0251 · Cited by 100
Do mutator mutations fuel tumorigenesis?
Fox, E. J., Prindle, M. J., & Loeb, L. A. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9426-8 · Cited by 99
Walzl, A., Unger, C., Kramer, N., Unterleuthner, D., Scherzer, M., Hengstschläger, M., Schwanzer-Pfeiffer, D., & Dolznig, H. (2014) · SLAS Discovery · doi:10.1177/1087057114532352 · Cited by 98
Amundadottir, L. T. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15001 · Cited by 110
Masgras, I., Ciscato, F., Brunati, A. M., Tibaldi, E. V., Indraccolo, S., Curtarello, M., Chiara, F., Cannino, G., Papaleo, E., Lambrughi, M., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.056 · Cited by 103
Metadata
- Authors
- Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 1999-07-29
- Volume
- 400
- Issue
- 6743
- Pages
- 464-468
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1545398558
- Cited by
- 2,345
- References
- 31
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 28 · 2023: 42 · 2022: 36 · 2021: 51 · 2020: 44 · 2019: 55 · 2018: 57 · 2017: 48 · 2016: 72 · 2015: 84 · 2014: 92 · 2013: 98 · 2012: 82
- FWCI
- 85.16
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2026-04-15)
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- malignant transformation, telomerase reverse transcriptase, SV40 large T antigen, oncogene cooperation, cell immortalization, human epithelial cells, human fibroblasts
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Adhesion, Cell Division, Cell Line, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Fibroblasts, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Genes, ras, RNA, Telomere, Telomerase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.